岗位介绍：

1.根据公司所从事的双特异抗体, 多特异抗体等PD-1后时代First-in-Class (FIC) 抗肿瘤药物研发之方向，开展商务工作，包括C轮融资，在研项目中、美授权转让等工作。

应聘要求：

1. 具有肿瘤免疫领域大分子新药研发经验3年以上且从事领域相关商务工作3年以上，有过项目转让或者融资成功案例。

2. 生物学相关硕士、博士或者MBA具有生物医药领域项目转让，创业公司早期阶段融资工作经验3年以上。

3. 具有非常强的沟通、交流、处事能力

4. 具有良好团队合作意识、敬业以及创新创业精神

职能类别：医药领域商务

关键字：新药研发商务

BD Manager or Director or VP,

L&L Biopharma Co., LTD., Shanghai, China (www.lnlbio.com) is a clinical-stage biotech focused on the development of novel therapies for the treatment of cancers. The company focuses on exploring the first in class (FIC) bispecific/trispecific antibody products targeting post PD-1 market. Two products Bis5 and Bis2 are currently on the phase I study. We are looking for BD talents in different level including manager, director or VP to join in our team.

Job responsibilities:

ü Identifies and develops business opportunities, including fund raising and product out-licensing

ü Builds partnerships for the phase I and II studies of Bis2 and/or Bis5 in China and US

ü Maintain and strengthens relationships with existing partnerships and investors

ü Based in Shanghai and/or New Jersey or other states in US

Qualifications and skills:

ü Strategic planning skills and knowledge of bi/tri-specific antibody for the treatment of cancers

ü Excellent presentation and communication skills

ü Ability to communicate accessibly and concisely about products to prospective partners and investors

ü Bachelor’s degree in business administration, marketing, economy or related field. MBA with experience in biologics biotech is highly preferred

ü 2+ years related experience is great